Pharmacological inhibition of HIF-1α has been tried in a multitude of cancers with limited success [33], most likely due to the complexity of the HIF-1α transcriptome, which contains not only genes that promote tumor cell survival but also genes that promote growth arrest [34] and tumor cell death [35]. The gene discussed is HIF1A; the disease is cancer.